# Pralidoxime

## Pampara inj 500mg/20mL

#### 一般可用

| 藥品代碼       | IPAM2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|:---------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Treatment of muscle weakness and/or respiratory depression secondary to poisoning due to organophosphate anticholinesterase pesticides and chemicals (eg， nerve agents); control of overdose of anticholinesterase medications used to treat myasthenia gravis (ambenonium， neostigmine， pyridostigmine)                                                                                                                                                                                                                                                           |
| 用法用量       | (仿單) Loading dose 1 g IV; may repeat bolus of 1 g after 30 minutes if symptoms have not been relieved.                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 肝功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 腎功能異常     | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 禁忌           | According to the manufacturer， relative contraindications include hypersensitivity to pralidoxime or any component of the formulation and other situations where the risk of administration clearly outweighs possible benefit.                                                                                                                                                                                                                                                                                                                                      |
| 副作用         | Cardiovascular: Cardiac arrest， hypertension， tachycardia Central nervous system: Dizziness， drowsiness， headache， paralysis， seizure Dermatologic: Skin rash Gastrointestinal: Nausea Hepatic: Increased serum ALT (transient)， increased serum AST (transient) Local: Pain at injection site (IM) Neuromuscular & skeletal: Fasciculations， increased creatine phosphokinase， laryngospasm， muscle rigidity， weakness Ophthalmic: Accommodation disturbance， blurred vision， diplopia Renal: Renal insufficiency Respiratory: Apnea， hyperventilation |
| 孕期用藥建議   | nan                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 哺乳期用藥建議 | Hold Breast Feeding 暫停哺乳                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |

